184 related articles for article (PubMed ID: 21168469)
1. TET genes: new players in DNA demethylation and important determinants for stemness.
Mohr F; Döhner K; Buske C; Rawat VP
Exp Hematol; 2011 Mar; 39(3):272-81. PubMed ID: 21168469
[TBL] [Abstract][Full Text] [Related]
2. The Ten-Eleven Translocation-2 (TET2) gene in hematopoiesis and hematopoietic diseases.
Solary E; Bernard OA; Tefferi A; Fuks F; Vainchenker W
Leukemia; 2014 Mar; 28(3):485-96. PubMed ID: 24220273
[TBL] [Abstract][Full Text] [Related]
3. TET proteins and 5-methylcytosine oxidation in hematological cancers.
Ko M; An J; Pastor WA; Koralov SB; Rajewsky K; Rao A
Immunol Rev; 2015 Jan; 263(1):6-21. PubMed ID: 25510268
[TBL] [Abstract][Full Text] [Related]
4. The TET2 interactors and their links to hematological malignancies.
Pan F; Weeks O; Yang FC; Xu M
IUBMB Life; 2015 Jun; 67(6):438-45. PubMed ID: 26099018
[TBL] [Abstract][Full Text] [Related]
5. TET2 as an epigenetic master regulator for normal and malignant hematopoiesis.
Nakajima H; Kunimoto H
Cancer Sci; 2014 Sep; 105(9):1093-9. PubMed ID: 25040794
[TBL] [Abstract][Full Text] [Related]
6. TET2 in Normal and Malignant Hematopoiesis.
Bowman RL; Levine RL
Cold Spring Harb Perspect Med; 2017 Aug; 7(8):. PubMed ID: 28242787
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic Function of TET Family, 5-Methylcytosine, and 5-Hydroxymethylcytosine in Hematologic Malignancies.
Li W; Xu L
Oncol Res Treat; 2019; 42(6):309-318. PubMed ID: 31055566
[TBL] [Abstract][Full Text] [Related]
8. TET-mediated DNA demethylation controls gastrulation by regulating Lefty-Nodal signalling.
Dai HQ; Wang BA; Yang L; Chen JJ; Zhu GC; Sun ML; Ge H; Wang R; Chapman DL; Tang F; Sun X; Xu GL
Nature; 2016 Oct; 538(7626):528-532. PubMed ID: 27760115
[TBL] [Abstract][Full Text] [Related]
9. Distinct and stage-specific contributions of TET1 and TET2 to stepwise cytosine oxidation in the transition from naive to primed pluripotency.
Mulholland CB; Traube FR; Ugur E; Parsa E; Eckl EM; Schönung M; Modic M; Bartoschek MD; Stolz P; Ryan J; Carell T; Leonhardt H; Bultmann S
Sci Rep; 2020 Jul; 10(1):12066. PubMed ID: 32694513
[TBL] [Abstract][Full Text] [Related]
10. Dysregulation of TET2 in hematologic malignancies.
Chiba S
Int J Hematol; 2017 Jan; 105(1):17-22. PubMed ID: 27848178
[TBL] [Abstract][Full Text] [Related]
11. Role of TET enzymes in DNA methylation, development, and cancer.
Rasmussen KD; Helin K
Genes Dev; 2016 Apr; 30(7):733-50. PubMed ID: 27036965
[TBL] [Abstract][Full Text] [Related]
12. [TET2 as a gatekeeper for hematologic malignancies].
Muto H; Sakata-Yanagimoto M; Chiba S
Rinsho Ketsueki; 2015 Jun; 56(6):651-6. PubMed ID: 26256875
[TBL] [Abstract][Full Text] [Related]
13. TET proteins: on the frenetic hunt for new cytosine modifications.
Delatte B; Fuks F
Brief Funct Genomics; 2013 May; 12(3):191-204. PubMed ID: 23625996
[TBL] [Abstract][Full Text] [Related]
14. PRDM14 promotes active DNA demethylation through the ten-eleven translocation (TET)-mediated base excision repair pathway in embryonic stem cells.
Okashita N; Kumaki Y; Ebi K; Nishi M; Okamoto Y; Nakayama M; Hashimoto S; Nakamura T; Sugasawa K; Kojima N; Takada T; Okano M; Seki Y
Development; 2014 Jan; 141(2):269-80. PubMed ID: 24335252
[TBL] [Abstract][Full Text] [Related]
15. 5-Hydroxymethylcytosine is an essential intermediate of active DNA demethylation processes in primary human monocytes.
Klug M; Schmidhofer S; Gebhard C; Andreesen R; Rehli M
Genome Biol; 2013 May; 14(5):R46. PubMed ID: 23705593
[TBL] [Abstract][Full Text] [Related]
16. TET family proteins and their role in stem cell differentiation and transformation.
Cimmino L; Abdel-Wahab O; Levine RL; Aifantis I
Cell Stem Cell; 2011 Sep; 9(3):193-204. PubMed ID: 21885017
[TBL] [Abstract][Full Text] [Related]
17. [Roles of ten eleven translocation proteins family and 5-hydroxymethylcytosine in epigenetic regulation of stem cells and regenerative medicine].
Zhao JF; Li D; An Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Feb; 53(2):420-424. PubMed ID: 33879920
[TBL] [Abstract][Full Text] [Related]
18. Perturbations of 5-hydroxymethylcytosine patterning in hematologic malignancies.
Madzo J; Vasanthakumar A; Godley LA
Semin Hematol; 2013 Jan; 50(1):61-9. PubMed ID: 23507484
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic alterations in hematopoietic malignancies.
Chung YR; Schatoff E; Abdel-Wahab O
Int J Hematol; 2012 Oct; 96(4):413-27. PubMed ID: 23015417
[TBL] [Abstract][Full Text] [Related]
20. MicroRNAs mediated targeting on the Yin-yang dynamics of DNA methylation in disease and development.
Tu J; Liao J; Luk AC; Tang NL; Chan WY; Lee TL
Int J Biochem Cell Biol; 2015 Oct; 67():115-20. PubMed ID: 25979370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
